Latest Articles

Article Type

Open Access
Health Service Use, Access, and Challenges for 2S/LGBTQIA+ Individuals with Rheumatic Conditions
Codie Primeau, Malhar Shah, Ren Lo, Tyrone Curtis, Anu Radha Verma and Nathan Lachowsky

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 109-110; DOI: https://doi.org/10.3899/jrheum.2026-0447.120
Open Access
Bimekizumab Clinical Efficacy Up to 2 Years Across Patients with Psoriatic Arthritis and Varying Baseline Joint Involvement: Results from a Post Hoc Analysis of 2 Pooled Phase 3 Studies
Philip Mease, Laure Gossec, Hideto Kameda, David Nicholls, Proton Rahman, Barbara Ink, Rajan Bajracharya, Patrick Healy and Laura Coates

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 87-88; DOI: https://doi.org/10.3899/jrheum.2026-0447.81
Open Access
Taming the Fire: Lung Sparing MDA-5 DM and MAS Overlap Successfully Treated with Methylprednisolone, Rituximab, IVIG, Anakinra, and Tofacitinib
Donovan Makus and Cristina Moran Toro

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 71-72; DOI: https://doi.org/10.3899/jrheum.2026-0447.52
Open Access
Patient Perspectives on the Use of their Home Pharmacies for Advanced Therapy Prescriptions in Rheumatology
Steven Katz and Jill Hall

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 114-115; DOI: https://doi.org/10.3899/jrheum.2026-0447.130
Open Access
Identifying and Supporting At-Risk Vasculitis Patients: Integrating Targeted Mental Health Screening and Psychology Referral into Rheumatology Care
Duncan Maguire, Iman Kassam, Pamela Mathura, Tarek Turk, Bo Pan, Lana Hawkins, Yazid Al Hamarneh and Elaine Yacyshyn

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 117; DOI: https://doi.org/10.3899/jrheum.2026-0447.136
Open Access
Brentuximab Vedotin in Severe Systemic Sclerosis: Data on Long-Term Follow-Up and Retreatment
Ibraheem Almani, Andreu Fernándes-Codina, Amanda Philip, Sara Hewitt and Janet Pope

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 150-151; DOI: https://doi.org/10.3899/jrheum.2026-0447.203
Open Access
Low Dose, High Impact: Acetylsalicylic Acid and Preterm Pre-Eclampsia Prevention in Rheumatic Disease
Sam Chan, Jeremiah Tan, Sofia Rieger-Torres, Mary De Vera and Neda Amiri

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 107-108; DOI: https://doi.org/10.3899/jrheum.2026-0447.117
Open Access
Effect of Guselkumab and IL-17 Inhibitors on Work Productivity and Activity Impairment in Psoriatic Arthritis: 6-Month Results of the PsABIOnd Observational Study
Proton Rahman, Stefan Siebert, Mohamed Sharaf, Frank Behrens, Mitsumasa Kishimoto, Enrique Soriano, Emmanouil Rampakakis, László Köleséri, Karissa Lozenski, Ruben Queiro Silva, Ennio Lubrano and Laure Gossec

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 120-121; DOI: https://doi.org/10.3899/jrheum.2026-0447.142
Open Access
Idiopathic AA Renal Amyloidosis Treated with Tocilizumab — A Case Report
Budvin Wijetillake, Rayan Farahvash, Elisabeth Pek and Jason An

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 67; DOI: https://doi.org/10.3899/jrheum.2026-0447.41
Open Access
Mixed-Methods Feasibility Study to Test Uptake of Quality Indicator Resources for Rehabilitation After Total Hip and Knee Replacement: Feasibility Outcomes
Marie Westby, Cheryl Koehn, Claire Barber, Deborah Marshall and Mourad Guirguis

The Journal of Rheumatology August 1 2026, 53 (Suppl 1) 116; DOI: https://doi.org/10.3899/jrheum.2026-0447.133

Main menu

User menu

Search

Latest Articles

Pages

Content

Resources

Subscribers

More